These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38567770)

  • 21. European Union health policy and its implications for national convergence.
    Cucic S
    Int J Qual Health Care; 2000 Jun; 12(3):217-25. PubMed ID: 10894193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brexit - Consequences for the UK's Oral Health Workforce?
    Eaton KA
    Community Dent Health; 2020 Feb; 37(1):3-4. PubMed ID: 32112675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European Health Care Systems and the Emerging Influence of European Union Competition Policy.
    Morton AJB
    J Health Polit Policy Law; 2021 Jun; 46(3):467-486. PubMed ID: 33647978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solidarity as a Political Determinant of Health: Insights from EU Competition Policy.
    Guy M
    J Health Polit Policy Law; 2024 Oct; 49(5):783-803. PubMed ID: 38567773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the EU shirking responsibility for its deforestation footprint in tropical countries? Power, material, and epistemic inequalities in the EU's global environmental governance.
    Kumeh EM; Ramcilovic-Suominen S
    Sustain Sci; 2023; 18(2):599-616. PubMed ID: 36845358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Draft EU regulation on paediatric medicines: some improvements but still far from perfect.
    Prescrire Int; 2006 Feb; 15(81):32-3. PubMed ID: 16548115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public health within the EU policy space: a qualitative study of Organized Civil Society (OCS) and the Health in All Policies (HiAP) approach.
    Franklin PK
    Public Health; 2016 Jul; 136():29-34. PubMed ID: 27062067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subnational responsibilities for healthcare and Austria's rejection of the EU's patients' rights directive.
    Kostera T
    Health Policy; 2013 Jul; 111(2):149-56. PubMed ID: 23602349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EU's Hospitality and Welcome Culture: Conceiving the "No Human Being Is Illegal" Principle in the EU Fundamental Freedoms and Migration Governance.
    Aliu A; Aliu D
    Hum Rights Rev; 2022; 23(3):413-435. PubMed ID: 37520641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Checkmating the Nutri-Score: Will Food Patriotism Prevent the Harmonization of Front-of-Pack Labeling Schemes within the EU?
    Ewert B
    J Health Polit Policy Law; 2024 Oct; 49(5):885-891. PubMed ID: 38567758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access and pricing of medicines for patients with rare diseases in the European Union: an industry perspective.
    Tafuri G; Bracco A; Grueger J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):381-389. PubMed ID: 34930086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European policies for public health in border regions: no European mindset as yet.
    van der Zanden BAM; Hoebe CJPA; Horstman K
    BMC Public Health; 2024 Mar; 24(1):746. PubMed ID: 38459505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJ.
    Borg JJ; Laslop A; Pani L; Maciulaitis R; Melchiorri D
    Sci Pharm; 2014; 82(3):541-54. PubMed ID: 25853067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the effectiveness of the EU's approach to the sustainable use of pesticides.
    Helepciuc FE; Todor A
    PLoS One; 2021; 16(9):e0256719. PubMed ID: 34529677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orphan Medicines for Pediatric Use: A Focus on the European Union.
    Bolislis WR; Corriol-Rohou S; Hill-Venning C; Hoogland H; Joos A; King D; Kitcatt V; Le Visage G; Kühler TC
    Clin Ther; 2019 Dec; 41(12):2630-2642. PubMed ID: 31704041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. China's impact on the European Union's Arctic policy: critical junctures, crossovers, and geographic shifts.
    Biedermann R
    Asia Eur J; 2021; 19(4):467-487. PubMed ID: 34093101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time for Change? The Why, What and How of Promoting Innovation to Tackle Rare Diseases - Is It Time to Update the EU's Orphan Regulation? And if so, What Should be Changed?
    Horgan D; Moss B; Boccia S; Genuardi M; Gajewski M; Capurso G; Fenaux P; Gulbis B; Pellegrini M; Mañú Pereira MDM; Gutiérrez Valle V; Gutiérrez Ibarluzea I; Kent A; Cattaneo I; Jagielska B; Belina I; Tumiene B; Ward A; Papaluca M
    Biomed Hub; 2020; 5(2):1-11. PubMed ID: 33564657
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.